MS HB283

Prohibits manufacturers and wholesale distributors of essential generic drugs from engaging in price gouging, defined as an unconscionable increase in prescription drug prices that is excessive, unjustified by production costs, and leaves consumers with no meaningful choice due to health necessity and insufficient competition.

Requires the Division of Medicaid and Department of Human Services to notify the Attorney General when an essential generic drug price increases 50% or more in wholesale acquisition cost or medical assistance program price within a one-year period.

Authorizes the Attorney General to request cost production itemization, access expansion expenditures, and public health improvements from manufacturers within 45 days, and to compel production of relevant records and documents.

Empowers the Attorney General to bring civil actions in Hinds County Circuit Court seeking injunctive relief, consumer restitution, price rollbacks for up to one year, and civil penalties of up to $100,000 per violation.

Takes effect July 1, 2019.